Will Ashworth

Will Ashworth

Expertise: Public and private companies, Portfolio construction

About Will:
Will Ashworth has written about investments full-time since 2008. He loves investing and is passionate about helping others put their money to work. He particularly enjoys creating model portfolios that stand the test of time.

Publications where he’s appeared include InvestorPlace, The Motley Fool Canada, Investopedia, Kiplinger, and several others in both the U.S. and Canada. He lives in Halifax, Nova Scotia.

You can follow Will on LinkedIn. 

Recent Articles

Disney Is Only One of Several Problems Facing AMC Entertainment Stock

AMC Entertainment’s failure to diversify could be undoing of AMC stock, not its gargantuan debt. If you're an AMC stock investor, you ought to be nervous. 

Will the Real Clover Health Stock Please Stand Up?

Clover Health trades near its 52-week low of $6.31, well off its 52-week high of $28.85 in June. Will the real CLOV stock please stand up?

Greenidge Generation Stock Is a Risky Play That Just Doesn’t Pass the Smell Test

Greenidge Generation Holdings lost 58% of its value Sep. 15, the first day of trading for GREE stock. It’s lost 41% in the six days since.      

Don’t Be Fooled by ChargePoint Stock’s Failure to Charge Into October

CHPT stock has struggled recently but remains an excellent speculative buy in the low $20s based on the company's outsized growth prospects.

Is Stellantis the Second Company to Jump on QuantumScape’s Bandwagon?

QuantumScape announced Sep. 21 that it will provide an unnamed automotive company with 10 MWh of battery capacity. That’s a win for QS stock. 

This Brilliant Move By Cardano Strengthens the Case to Own ADA

Just when I’d given up on Cardano, the people behind it come up with a commonsense idea that strengthen the argument for owning ADA-USD. 

SoFi Technologies Stock Has Too Much Going for It to Let Cash Burn Scare You Away

As I write this, SoFi Technologies is up 21% in September. A repeat in October gets SOFI stock over $20 for the first time since late June.    

With the Crickets Chirping at Zomedica HQ, Why Buy the Stock?

The only word out of Zomedica in September was its announcement of a new director. That’s not the news ZOM stock needs right now.

Ripple Lacks Strong Institutional Buyers, and That’s a Problem

A solid cryptocurrency, much like a stock, has high institutional ownership. On this front, Ripple is lagging behind its crypto peers.

7 Best Stocks To Buy for Investors Building a ‘Brands’ Portfolio

Authentic Brands will soon go public making it the 35th U.S.-listed stock with “Brands” in the name. Here are seven stocks to buy to build your brand portfolio.